Document is current
Any future updates will be listed below
-
Authors
Setton, Jeremy
Hadi, Kevin
Choo, Zi-Ning
Kuchin, Katherine S.
Tian, Huasong
Da Cruz Paula, Arnaud
Rosiene, Joel https://orcid.org/0000-0002-8610-370X
Selenica, Pier
Behr, Julie
Yao, Xiaotong https://orcid.org/0000-0002-5140-6639
Deshpande, Aditya
Sigouros, Michael https://orcid.org/0000-0002-0328-8359
Manohar, Jyothi
Nauseef, Jones T. https://orcid.org/0000-0003-2302-4171
Mosquera, Juan-Miguel https://orcid.org/0000-0003-4666-6476
Elemento, Olivier https://orcid.org/0000-0002-8061-9617
Weigelt, Britta https://orcid.org/0000-0001-9927-1270
Riaz, Nadeem https://orcid.org/0000-0001-9873-5862
Reis-Filho, Jorge S. https://orcid.org/0000-0003-2969-3173
Powell, Simon N. https://orcid.org/0000-0002-8183-4765
Imieliński, Marcin https://orcid.org/0000-0002-2211-4741
- License Information
-
More Information
Article History
Received: 18 August 2021
Accepted: 20 July 2023
First Online: 16 August 2023
Competing interests
: J.S.R.-F. reports receiving personal or consultancy fees from Goldman Sachs, Bain Capital, REPARE Therapeutics and Paige.AI, membership of the scientific advisory boards of VolitionRx, REPARE Therapeutics, Personalis and Paige.AI, membership of the Board of Directors of Grupo Oncoclinicas and ad hoc membership of the scientific advisory boards of Roche Tissue Diagnostics, Ventana Medical Systems, Novartis, Genentech, Merck, Daiichi Sankyo and AstraZeneca, outside the scope of this study. B.W. reports ad hoc membership of the scientific advisory board of REPARE Therapeutics. S.N.P. reports the following: consulting fees: Varian Medical Systems, Philips Healthcare, AstraZeneca; research funding: Philips Healthcare, Varian Medical Systems. M.I. is a member of the scientific advisory board of ImmPACT Bio.
